
    
      The primary objectives of this post-market surveillance study are to support short-term
      safety of the device and procedure, to further assess long-term safety and effectiveness, and
      to assess the safety profile in subjects treated by newly trained providers of the Ellipsys
      Vascular Access System in the creation of a native AV fistula via percutaneous access in
      subjects who are on hemodialysis and are medically indicated for the creation of an upper
      limb anastomosis.
    
  